Clinical Trial Update: A Phase I Trial of Tumor-Associated Lymph Node T-Cell Injection With Advanced Malignant Solid Tumors [Phase 1]

View source ↗

Summary

Phase I trial assessing Tumor-Associated Lymph Node T-Cell Injection alone or with Serplulimab for patients with advanced malignant solid tumors; currently recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• Serplulimab (serplulimab)
• Tumor-Associated Lymph Node T-Cell Injection

Snippet

Sponsor: Guangzhou FineImmune Biotechnology Co., LTD. | Conditions: Tumor Associated Lymph Node T Cell, Advanced Solid Tumor | Phase 1 | Status: RECRUITING